The Era of Borderless Data Is Ending
The New York Times
Nations are accelerating efforts to control data produced within their perimeters, disrupting the flow of what has become a kind of digital currency.
More Related News
Lawmakers raising national security concerns and seeking to disconnect a major Chinese firm from U.S. pharmaceutical interests have rattled the biotech industry. The firm is deeply involved in development and manufacturing of crucial therapies for cancer, cystic fibrosis, H.I.V. and other illnesses.